Fouad has worked to establish the validity of health disparities as a national scientific research priority.
Published in Faculty Excellence
This grant will fully support Kendra Royston’s research work within the UAB College of Arts and Sciences’ Department of Biology throughout the spring of 2018.
Published in Student Experience
Researchers use compounds found in a combination plant-based diet to successfully prevent and treat ER-negative breast cancer in mice.
Published in Focus on Patient Care
Chad Thomas Hagwood, Edward E. Partridge, Catherine Danielou, Michelle Cardel and Raymond Thompson were bestowed the awards by the NAS for their personal, academic and professional achievements, service to the community, and philanthropy.
A blue-light cystoscopy may detect certain bladder cancer tumors more than the use of standard white-light diagnostic testing.
Published in Focus on Patient Care
Hadiyah-Nicole Green, UAB alumna, will be recognized by GE in a Grand Central Station display for research in cancer treatment.

Alina Franke registered to donate her bone marrow in Hamburg, Germany, in 2009. She wound up being the one person in 24 million around the world on the Be The Match registry to be the perfect match that Jimmy Roberson needed.

Published in Focus on Patient Care

These new results, led by primary author Warner Huh, M.D., strengthen the promise that vaccination with Gardasil 9 can reduce 90 percent of cervical cancers.

UAB provides ovarian cancer care beyond traditional interventions to include nutrition, supportive care, counseling and genetic testing.
Published in Focus on Patient Care
This gene silencing by ubiquitinated histone is vital in normal embryo development, and it goes awry in some cancers.
Health care provider recommendation of HPV vaccines could help decrease secondary cancers in childhood cancer survivors.
Published in Focus on Patient Care
An art event will be held Aug. 17 to engage the cancer community in the healing power of art.
Published in Service to Community
This potential chemotherapeutic agent to treat glioblastoma — a primary brain tumor with dismal survival rates — is a novel small molecule inhibitor.
UAB is the only institution in Alabama chosen to date to participate in the TAPUR Study to help further understand targeted therapies in patients with advanced cancers.
Published in Focus on Patient Care
This active drug-delivery system addresses the limitations seen for the anti-cancer drug BA-TPQ — poor solubility and low bioavailability.
Recent findings from an innovative nationwide trial indicate that the drug pembrolizumab, when used in combination with standard therapy, may provide positive results for patients with locally advanced breast cancer.
Published in Focus on Patient Care
The new UAB Breast Cancer Survivorship Clinic provides breast cancer patients extended follow-up care, helping them adjust to physical and emotional changes after treatment.
Published in Focus on Patient Care
The UAB Cancer Center offers patients with advanced and rare cancer, including those with any stage of pancreatic and brain cancer, the opportunity to have no-cost tumor profiling, and patients may be matched with an appropriate clinical trial or recommend use of an FDA-approved drug.
Published in Focus on Patient Care
The annual symposium May 15 will provide help and support for cancer patients and survivors.
Published in Focus on Patient Care
The University of Alabama at Birmingham announces a partnership with Guideway Care to expand the reach of UAB’s proven cancer navigation program, Patient Care Connect, to patients nationally.
Published in Focus on Patient Care
Page 1 of 15
Back to Top